- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Phenylketonuria
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 412KB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 71KB)
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine – November 2022
Glycomacropeptide Formula with Long Chain Polyunsaturated Fatty Acids and Docosahexaenoic Acid and Low in Phenylalanine: Oral liquid, 237 mL, 15 (PKU Sphere Liquid); PKU Sphere Liquid
Last updated
6 July 2023